TransMedics to Present at the William Blair 46th Annual Growth Stock Conference

Rhea-AI Summary

TransMedics (Nasdaq:TMDX) will participate in the William Blair 46th Annual Growth Stock Conference in Chicago on June 2, 2026. Management presents at 2:20 p.m. ET / 1:20 p.m. CT, with live and archived webcasts available on the company’s investor relations website.

News Market Reaction – TMDX

+2.83%

2 alerts

+2.83% Session close to close

$2.44B Market Cap

0.3x Rel. Volume

In the May 20 session, TMDX gained 2.83%, reflecting a moderate positive market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights TransMedics’ participation in a major growth-stock conference on June 2...

Analysis

This announcement highlights TransMedics’ participation in a major growth-stock conference on June 2, 2026, with a webcast available to investors. It fits a broader pattern of active investor outreach alongside recent earnings, clinical program progress, and logistics expansion. Investors may focus on updated messaging around growth guidance, margin trends, and capital deployment. Monitoring future earnings releases, clinical milestones, and any strategic transactions will be important for assessing execution against stated goals.

Key Figures

Conference edition: 46th Annual Conference date: June 2, 2026 Presentation time ET: 2:20 p.m. ET +1 more

4 metrics

Conference edition 46th Annual William Blair Growth Stock Conference

Conference date June 2, 2026 Scheduled presentation in Chicago

Presentation time ET 2:20 p.m. ET Management presentation start time

Presentation time CT 1:20 p.m. CT Local Chicago presentation time

Historical Context

5 past events · Latest: May 05 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 05	Q1 2026 earnings	Neutral	-23.2%	Reported Q1 revenue growth and guidance reiteration with margin pressure.
Apr 29	Strategic investment	Positive	-2.7%	Announced plan to invest in PAD Aviation for European logistics network.
Apr 29	Sector feature article	Neutral	-2.7%	Industry piece highlighting medtech capital shift and new product launch.
Apr 23	Clinical program update	Positive	-1.3%	Unveiled CHOPS system and detailed ENHANCE Heart and DENOVO Lung plans.
Apr 21	Earnings date notice	Neutral	+4.0%	Scheduled first quarter 2026 results and conference call details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent history shows multiple instances where TMDX shares moved negatively or counterintuitively following earnings, clinical, and strategic updates that were largely positive or neutral in tone.

Recent Company History

Over the last few months, TransMedics reported strong Q1 2026 revenue growth and reiterated 2026 guidance, yet the stock fell sharply after earnings. Strategic moves like the planned PAD Aviation investment and launch of the CHOPS preservation system also coincided with modest declines. Earlier, announcing the May 5 earnings date produced a small gain. Against this backdrop, the William Blair conference appearance fits a pattern of ongoing investor outreach amid volatility following operational updates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ANDOVER, Mass., May 19, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in the William Blair 46th Annual Growth Stock Conference in Chicago on Tuesday, June 2, 2026. The TransMedics management team will present beginning at 2:20 p.m. ET/ 1:20 p.m. CT.

A live and archived webcast of the presentations will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
Hannah Jeffrey
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-the-william-blair-46th-annual-growth-stock-conference-302776706.html

SOURCE TransMedics Group, Inc.

FAQ

When will TransMedics (TMDX) present at the William Blair 46th Annual Growth Stock Conference?

TransMedics will present on June 2, 2026, at 2:20 p.m. ET. The company’s management team will speak at the William Blair 46th Annual Growth Stock Conference in Chicago, offering investors insights into its business and strategy.

What time is TransMedics (TMDX) presentation at the William Blair 2026 Growth Stock Conference?

TransMedics’ presentation is scheduled for 2:20 p.m. ET / 1:20 p.m. CT. According to the company, its management team will address investors during the William Blair 46th Annual Growth Stock Conference in Chicago on June 2, 2026.

How can investors watch the TransMedics (TMDX) webcast from the William Blair Growth Stock Conference?

Investors can watch a live and archived webcast on TransMedics’ investor relations website. According to the company, access is available through the “Investors” section at its dedicated URL, covering the June 2, 2026 conference presentation.

Will a replay of the TransMedics (TMDX) William Blair conference presentation be available?

Yes, an archived webcast of TransMedics’ presentation will be available after the event. According to the company, both live and archived webcasts can be accessed through the Investors section of its website for ongoing investor review.

Where can I find the TransMedics (TMDX) standard investor presentation for the William Blair conference?

TransMedics’ standard investor presentation is available through the same investor relations link hosting the webcast. According to the company, investors can access this presentation in the “Investors” section of its website for additional background information.

What is the significance of TransMedics (TMDX) attending the William Blair 46th Annual Growth Stock Conference?

Attending the William Blair conference gives TransMedics exposure to growth-focused investors. The company’s management will present its medical technology business and organ transplant platform, supported by a webcast and standard investor presentation accessible via its investor relations website.